We can’t show the full text here under this license. Use the link below to read it at the source.
An Ionizable Lipid Material with a Vitamin E Scaffold as an mRNA Vaccine Platform for Efficient Cytotoxic T Cell Responses
An Ionizable Lipid with a Vitamin E Base for mRNA Vaccines that Boost Killer T Cell Responses
AI simplified
Abstract
An RNA vaccine using with a vitamin E scaffold induced OVA-specific cytotoxic T cell responses and showed an antitumor effect against an E.G7-OVA tumor model.
- The vaccine demonstrated an enhanced ability to induce cellular immunity through a novel ionizable lipid.
- Vaccination conferred protection against lethal infection using the TgPF antigen.
- Type I interferon response, dependent on the vitamin E scaffold, was crucial for the differentiation of effector CD8 T cells.
- Conventional dendritic cells were essential for eliciting CD8 T cell responses from the mRNA-lipid nanoparticles.
- The cDC2 subset of dendritic cells, rather than cDC1, selectively transfected by the mRNA-lipid nanoparticles, facilitated antigen presentation.
AI simplified
Key numbers
Higher than control
OVA-specific Increase
induced superior compared to conventional vectors.
10 of 10 mice
Survival Rate
Mice immunized with mTgPF- showed full survival after challenge.